Can microbiota modulation prevent the development of fatty liver disease?

Abstract

Can microbiota modulation prevent the development of fatty liver disease? The work described in this article is part of the Marie Skłodowska-Curie Innovative Training Network “Building a Gut Microbiome Engineering Toolbox for In-Situ Therapeutic Treatments for Nonalcoholic Fatty Liver Disease”. We aim to develop new microbial therapies for the treatment of non-alcoholic fatty liver disease (NAFLD). Various strains from the Bacteroidetes phylum were investigated for beneficial traits protecting against NAFLD.